CD8A and neoplasm: These RT-induced immunogenic responses can result in the uptake of tumor-associated antigens (TAAs) by dendritic cells (DCs) that present them to cytotoxic CD8+ T-cells recruited from circulatory system, subsequently priming and activating the anti-tumor immunity response (15).